This Workshop took place at LSI Europe ‘25 Emerging Medtech Summit in London.Investment leaders from Watershed Therapeutics, Earlybird Health, and Segulah Medical Acceleration discuss which patient outcomes are most compelling to investors, offering strategic insights for medtech companies seeking funding in this interactive workshop session.This Workshop featured:Christopher Kinsella — Watershed TherapeuticsThom Rasche — Earlybird Health Management GmbH & Co. KGKarin Leire — Segulah Medical AccelerationJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw
